Ventyx Biosciences Stock Analysis

Ventyx Stock Analysis Notes

About 85.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 0.37. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Ventyx Biosciences recorded a loss per share of 1.97. The entity had not issued any dividends in recent years. Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California. Ventyx Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people. For more information please call Raju Mohan at 760 593 4832 or visit https://ventyxbio.com.

Ventyx Biosciences Investment Alerts

Ventyx Biosciences Upcoming and Recent Events

Ventyx Largest EPS Surprises

View All Earnings Estimates

Ventyx Stock Institutional Investors

Note, although Ventyx Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ventyx Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 93.89 M.

Ventyx Profitablity

Management Efficiency

Ventyx Biosciences has return on total asset (ROA) of (0.3348) % which means that it has lost $0.3348 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5427) %, meaning that it created substantial loss on money invested by shareholders. Ventyx Biosciences' management efficiency ratios could be used to measure how well Ventyx Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.51 in 2025. Return On Capital Employed is likely to rise to -0.53 in 2025. At this time, Ventyx Biosciences' Net Tangible Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 38.5 M in 2025, whereas Total Assets are likely to drop slightly above 223.3 M in 2025.

Technical Drivers

As of the 24th of March, Ventyx Biosciences has the Coefficient Of Variation of (618.77), risk adjusted performance of (0.14), and Variance of 20.2. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Ventyx Biosciences, as well as the relationship between them.

Ventyx Biosciences Price Movement Analysis

Ventyx Biosciences Insider Trading Activities

Ventyx Biosciences Outstanding Bonds

Ventyx Biosciences Predictive Daily Indicators

Ventyx Biosciences Forecast Models

Ventyx Biosciences' time-series forecasting models are one of many Ventyx Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ventyx Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ventyx Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ventyx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ventyx Biosciences. By using and applying Ventyx Stock analysis, traders can create a robust methodology for identifying Ventyx entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ventyx analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ventyx analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Ventyx Biosciences stock analysis indicators help investors evaluate how Ventyx Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ventyx Biosciences shares will generate the highest return on investment. By understating and applying Ventyx Biosciences stock analysis, traders can identify Ventyx Biosciences position entry and exit signals to maximize returns.

When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.